BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 8955172)

  • 1. Induction of anergy in CD8 T cells by B cell presentation of antigen.
    Höllsberg P; Batra V; Dressel A; Hafler DA
    J Immunol; 1996 Dec; 157(12):5269-76. PubMed ID: 8955172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13.
    Fasler S; Aversa G; Terr A; Thestrup-Pedersen K; de Vries JE; Yssel H
    J Immunol; 1995 Nov; 155(9):4199-206. PubMed ID: 7594575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirements for stimulation or anergy induction in alloreactive human T cell clones.
    Pawelec G; Kalbacher H; Pohla H; Boshell M; Max H; Friccius H; Adibzadeh M; Hambrecht A; Sansom D
    Cell Immunol; 1994 Oct; 158(1):241-52. PubMed ID: 7522128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation.
    Hermann P; Van-Kooten C; Gaillard C; Banchereau J; Blanchard D
    Eur J Immunol; 1995 Oct; 25(10):2972-7. PubMed ID: 7589100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-4-producing CD8+ T cell clones can provide B cell help.
    Cronin DC; Stack R; Fitch FW
    J Immunol; 1995 Apr; 154(7):3118-27. PubMed ID: 7897202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L.
    Ranheim EA; Kipps TJ
    Cell Immunol; 1995 Apr; 161(2):226-35. PubMed ID: 7535196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional similarity and differences between selection-independent CD4-CD8- alphabeta T cells and positively selected CD8 T cells expressing the same TCR and the induction of anergy in CD4-CD8- alphabeta T cells in antigen-expressing mice.
    Caveno J; Zhang Y; Motyka B; Teh SJ; Teh HS
    J Immunol; 1999 Aug; 163(3):1222-9. PubMed ID: 10415017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated B cells express CD28/B7-independent costimulatory activity.
    Ding L; Shevach EM
    J Immunol; 1996 Aug; 157(4):1389-96. PubMed ID: 8759718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4.
    Macaulay AE; DeKruyff RH; Goodnow CC; Umetsu DT
    J Immunol; 1997 May; 158(9):4171-9. PubMed ID: 9126977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression.
    Wu HY; Monsonego A; Weiner HL
    J Autoimmun; 2006 Mar; 26(2):116-26. PubMed ID: 16426816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells.
    Johnson-Léger C; Christenson JR; Holman M; Klaus GG
    J Immunol; 1998 Nov; 161(9):4618-26. PubMed ID: 9794390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of CD80 expression by fibroblast-like synoviocytes leading to anergy in T lymphocytes.
    Corrigall VM; Solau-Gervais E; Panayi GS
    Arthritis Rheum; 2000 Jul; 43(7):1606-15. PubMed ID: 10902766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2, but not interleukin-15, is required to terminate experimentally induced clonal T-cell anergy.
    Bendiksen S; Rekvig OP
    Scand J Immunol; 2004; 60(1-2):64-73. PubMed ID: 15238074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis.
    Blotta MH; Marshall JD; DeKruyff RH; Umetsu DT
    J Immunol; 1996 May; 156(9):3133-40. PubMed ID: 8617933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of responsiveness in superantigen-induced anergic T cells. Role of ligand density and costimulatory signals.
    Heeg K; Wagner H
    J Immunol; 1995 Jul; 155(1):83-92. PubMed ID: 7602125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells.
    Fields PE; Finch RJ; Gray GS; Zollner R; Thomas JL; Sturmhoefel K; Lee K; Wolf S; Gajewski TF; Fitch FW
    J Immunol; 1998 Nov; 161(10):5268-75. PubMed ID: 9820499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
    Fenton RG; Turcovski-Corrales SM; Taub DD
    J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloantigen presentation by B cells: analysis of the requirement for B-cell activation.
    Wilson JL; Cunningham AC; Kirby JA
    Immunology; 1995 Nov; 86(3):325-30. PubMed ID: 8550066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.